Skip to content
2000
Volume 10, Issue 1
  • ISSN: 2667-3371
  • E-ISSN: 2667-338X
Preview this article:

There is no abstract available.

Loading

Article metrics loading...

/content/journals/adctra/10.2174/0126673371327363240911071617
2024-09-22
2025-01-19
Loading full text...

Full text loading...

/deliver/fulltext/adctra/10/1/ADCTRA-10-E26673371327363.html?itemId=/content/journals/adctra/10.2174/0126673371327363240911071617&mimeType=html&fmt=ahah

References

  1. UnissaM. The role of regulatory affairs in the pharmaceutical industries: A review.J Pharm Res Technol20231117
    [Google Scholar]
  2. KumarS. PanwarR. SinghU. Regulatory affairs in the pharmacy curriculum.Int J Res Develop Pharm Life Sci201326690698
    [Google Scholar]
  3. RaoN.R. TiwariA. PalA. PathakA. MauryaA. AliI. Overview of drug regulatory affairs and role of regulatory affairs in a pharmaceutical industry.Pak. Heart J.2023562986998
    [Google Scholar]
  4. RoshanK. AayushJ. Role of regulatory affairs in pharmaceutical company: An overview.Glob. J. Res. Anal.20187122778160
    [Google Scholar]
  5. BadheP WaghT ShirapureK. A review on the role of regulatory affairs in the pharmaceutical industry.
    [Google Scholar]
  6. JanjalV.S. DhamodkarS.R. JadhaoY.P. ManmodeS.B. PawarA.K. KhandelwalH.R. Recent drug regulatory affair and CTD module progress review for submission of pharmaceuticals product.GSC Biol Pharm Sci202116320022110.30574/gscbps.2021.16.3.0279
    [Google Scholar]
  7. ChiodinD. CoxE.M. EdmundA.V. KratzE. LockwoodS.H. Regulatory affairs 101: introduction to investigational new drug applications and clinical trial applications.Clin. Transl. Sci.201912433434210.1111/cts.1263530884199
    [Google Scholar]
  8. KumarBJ Overview of drug regulatory affairs and regulatory profession.Int J Drug Regul Aff.2013111410.22270/ijdra.v1i1.1
    [Google Scholar]
  9. LaleS. KendreA. GandhiM. DaniS. Role of drug regulatory affairs in pharma industry.World J Pharm Res SJIF201546615625
    [Google Scholar]
  10. MahaparaleS DesaiB Role and overview of drug regulatory affairs in the pharmaceutical industry with implementation of CTD and ECTD.World J Pharm Res201810.20959/wjpr20187‑11267.
    [Google Scholar]
  11. HandooS. KheraD. NandiP.K. SahuS.K. AroraV. A comprehensive study on regulatory requirements for development and filing of generic drugs globally.Int. J. Pharm. Investig.2012239910510.4103/2230‑973X.10439223373001
    [Google Scholar]
  12. CordeiroM.A. VitorinoC. SinogasC. SousaJ.J. A Regulatory perspective on biosimilar medicines.Pharmaceutics202416332110.3390/pharmaceutics1603032138543215
    [Google Scholar]
  13. AroteK.S. SaladeD.A. PatilN.V. A brief review on regulatory affairs: ensuring compliance, safety, and market access.Int. J. Pharma Sci.2023191
    [Google Scholar]
  14. SanghiD.K. TiwleR. Role of regulatory affairs in a pharmaceutical industry.IJPRR201442127131
    [Google Scholar]
/content/journals/adctra/10.2174/0126673371327363240911071617
Loading
/content/journals/adctra/10.2174/0126673371327363240911071617
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test